Immune stimulating macrolide
US10919927B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2018 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Feb 22, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides immune stimulating macrolide of formula (I). The macrolide has utility in treating viral diseases and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.